Piramal Pharma Ltd News

Piramal Pharma eyes mid-teens growth in FY27, prioritises organic expansion

Higher capacity utilisation, operating leverage and broad-based demand across CDMO, hospital generics and consumer healthcare are expected to support margins in FY27

Glenmark, Biocon, Aurobindo slip 3% on Trump's generic drug tariff plan

The US President Donald Trump announced a proposal to impose phased tariff (up to 200%) regime on imported generic medicines aimed at encouraging pharmaceutical manufacturing within the United States.

Trading ideas today: Piramal Pharma, Authum Investment, Vaibhav Global

Kunal Kamble of Bonanza has recommended three stocks to buy today - Piramal Pharma, Authum Investment, Vaibhav Global

Piramal Pharma shares rise 4% on successful closure of US FDA inspection

Piramal Pharma said that the US FDA has issued an Establishment Inspection Report (EIR) for its Sellersville facility, and the inspection has now been successfully closed.

Stocks to buy: Piramal Pharma, HSCL among 3 top bets by Choice Broking

Stocks to buy: Here's why Aakash Shah, technical analyst at Choice Broking recommends a 'Buy' on Piramal, Aza Engineering and Himadri Speciality Chemical this week.

Nifty Pharma extends rally, up 2%; Piramal Pharma, Laurus gain up to 10%

Analysts said that a combination of defensive buying, strong earnings visibility, export tailwinds, and sector rotation is driving the rally in pharma stocks.

Piramal Pharma to stay away from generic GLP-1 race amid global rush

Piramal Pharma is avoiding the crowded GLP-1 peptide market, focusing instead on niche therapies and specialised manufacturing to drive CDMO growth in FY27

Piramal Pharma bets on FY27 rebound; expects mid-teens growth, margin gains

Piramal Pharma expects a recovery in FY27 with mid-teens revenue growth and improved margins, supported by CDMO rebound, stronger order inflows, and global supply chain shifts

Stocks to Watch today: Eternal, Ceat, Bandhan Bank, GRSE, Canara HSBC Life

Stocks to Watch today, April 29, 2026: Eternal, Ceat, Bandhan Bank, BHEL, Mobikwik, and Canara HSBC Life Insurance are some of the key stocks to watch today

Nifty Pharma index soars 3%; Dr Reddy's, Piramal Pharma rally up to 9%

Glenmark Pharma, Cipla, Wockhardt, Mankind Pharma, Lupin, Zydus Life, Laurus, Ipca Labs, Divis Labs, Strides Pharma and Onesource were up in the range of 3% to 6%.

Patent wins vs tariff risks: Analysts pick top pharma stocks to bet on

Pharma stocks have, so far, outperformed the markets in 2026. However, as risk around Trump tariffs resurface, analysts suggest shifting to domestic-focused companies. Here's the investment strategy.

Nifty Pharma index falls for 4th day, sinks 4% as new US tariff risks mount

Nifty Pharma index today: The Trump administration may announce new tariffs on drugmakers that have not struck deals guaranteeing low prices in the country

Stocks to Watch today, Feb 16: Ola Electric, Kfin Tech, Inox Green, HUL

Stocks to Watch today, Feb 16: From Ola Electric to Inox Green Energy, here are few stocks that will be on investors' radar